Literature DB >> 13605685

[Reserpine therapy].

W OSWALD.   

Abstract

Keywords:  RESERPINE/therapeutic use

Mesh:

Substances:

Year:  1958        PMID: 13605685     DOI: 10.1007/bf01226506

Source DB:  PubMed          Journal:  Acta Neuroveg (Wien)        ISSN: 0375-9245


× No keyword cloud information.
  13 in total

1.  [Therapy of arterial hypertension].

Authors:  O H ARNOLD
Journal:  Dtsch Med Wochenschr       Date:  1955-10-14       Impact factor: 0.628

2.  [Clinical experiences in drug therapy of hypertension].

Authors:  W CRECELIUS
Journal:  Arztl Wochensch       Date:  1955-10-14

3.  The pharmacology of Rauwolfia.

Authors:  H J BEIN
Journal:  Pharmacol Rev       Date:  1956-09       Impact factor: 25.468

4.  [Comparative clinical studies on the effect of hydrazinophthalazine and Rauwolfia alkaloid reserpin on the blood pressure].

Authors:  K KUHNS; R DJURANOVIC; C GEHRS; K KOPPEN
Journal:  Klin Wochenschr       Date:  1954-10-01

5.  [Therapy of hypertension with a pure alkaloid of Rauwolfia serpentina].

Authors:  H MEYER-LEDDIN
Journal:  Med Klin       Date:  1954-02-19

6.  Contribution to the study of acetylcholine 'depot'.

Authors:  E FROMMEL; A BISCHLER; V BISCHLER
Journal:  Schweiz Med Wochenschr       Date:  1947-03-29

7.  [Therapy of hypertension with serpasil, a Rauwolfia alkaloid; clinical studies].

Authors:  W LOFFLER; A F ESSELLIER; F PROTT; A WEGMANN
Journal:  Schweiz Med Wochenschr       Date:  1953-10-17

8.  [Therapy of arterial hypertension with reserpin].

Authors:  G DAMM; H TRAUTNER
Journal:  Dtsch Med Wochenschr       Date:  1954-01-01       Impact factor: 0.628

9.  [Serpasil, an alkaloid of Rauwolfia serpentina, in therapy of hypertension].

Authors:  L HENSLER
Journal:  Schweiz Med Wochenschr       Date:  1953-11-28

10.  [Experimental studies on serpasil (reserpin) a new and very effective Rauwolfia alkaloid with analeptic effect].

Authors:  H J BEIN; F GROSS; J TRIPOD; R MEIER
Journal:  Schweiz Med Wochenschr       Date:  1953-10-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.